Nuclera Nucleics Ltd., headquartered in Great Britain, is a pioneering company in the biotechnology sector, specialising in the development of innovative DNA synthesis technologies. Founded in 2018, Nuclera has quickly established itself as a leader in the field, focusing on rapid and cost-effective solutions for synthetic biology applications. The company’s core offerings include its proprietary enzyme-based DNA synthesis platform, which stands out for its speed and efficiency, enabling researchers to accelerate their projects significantly. With a commitment to advancing genetic research, Nuclera has achieved notable milestones, including collaborations with leading academic institutions and biotech firms. As a key player in the synthetic biology market, Nuclera Nucleics Ltd. continues to drive innovation, positioning itself at the forefront of DNA synthesis technology and contributing to advancements in genomics and biotechnology.
How does Nuclera Nucleics Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Nuclera Nucleics Ltd's score of 26 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Nuclera Nucleics Ltd, headquartered in Great Britain, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and formal commitments suggests that Nuclera Nucleics Ltd may still be in the early stages of developing a comprehensive climate strategy. As the industry increasingly prioritises sustainability, it will be essential for the company to establish clear climate commitments and reduction initiatives to align with global standards and expectations.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Nuclera Nucleics Ltd has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
